» Articles » PMID: 11602760

Folding of Hepatitis C Virus E1 Glycoprotein in a Cell-free System

Overview
Journal J Virol
Date 2001 Oct 17
PMID 11602760
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The hepatitis C virus (HCV) envelope proteins, E1 and E2, form noncovalent heterodimers and are leading candidate antigens for a vaccine against HCV. Studies in mammalian cell expression systems have focused primarily on E2 and its folding, whereas knowledge of E1 folding remains fragmentary. We used a cell-free in vitro translation system to study E1 folding and asked whether the flanking proteins, Core and E2, influence this process. We translated the polyprotein precursor, in which the Core is N-terminal to E1, and E2 is C-terminal, and found that when the core protein was present, oxidation of E1 was a slow, E2-independent process. The half-time for E1 oxidation was about 5 h in the presence or absence of E2. In contrast with previous reports, analysis of three constructs of different lengths revealed that the E2 glycoprotein undergoes slow oxidation as well. Unfolded or partially folded E1 bound to the endoplasmic reticulum chaperones calnexin and (with lower efficiency) calreticulin, whereas no binding to BiP/GRP78 or GRP94 could be detected. Release from calnexin and calreticulin was used to assess formation of mature E1. When E1 was expressed in the absence of Core and E2, its oxidation was impaired. We conclude that E1 folding is a process that is affected not only by E2, as previously shown, but also by the Core. The folding of viral proteins can thus depend on complex interactions between neighboring proteins within the polyprotein precursor.

Citing Articles

Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.

Prentoe J, Janitzek C, Velazquez-Moctezuma R, Goksoyr L, Olsen R, Fanalista M PLoS One. 2021; 16(7):e0255336.

PMID: 34329365 PMC: 8323887. DOI: 10.1371/journal.pone.0255336.


Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.

Lavie M, Hanoulle X, Dubuisson J Front Immunol. 2018; 9:910.

PMID: 29755477 PMC: 5934428. DOI: 10.3389/fimmu.2018.00910.


Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex.

Grzyb K, Czarnota A, Brzozowska A, Cieslik A, Rabalski L, Tyborowska J Sci Rep. 2016; 6:30627.

PMID: 27481352 PMC: 4969751. DOI: 10.1038/srep30627.


Chaperones in hepatitis C virus infection.

Khachatoorian R, French S World J Hepatol. 2016; 8(1):9-35.

PMID: 26783419 PMC: 4705456. DOI: 10.4254/wjh.v8.i1.9.


Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design.

Tarr A, Khera T, Hueging K, Sheldon J, Steinmann E, Pietschmann T Viruses. 2015; 7(7):3995-4046.

PMID: 26193307 PMC: 4517138. DOI: 10.3390/v7072809.


References
1.
Scheele G, Jacoby R . Conformational changes associated with proteolytic processing of presecretory proteins allow glutathione-catalyzed formation of native disulfide bonds. J Biol Chem. 1982; 257(20):12277-82. View

2.
Dubuisson J, Rice C . Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin. J Virol. 1996; 70(2):778-86. PMC: 189879. DOI: 10.1128/JVI.70.2.778-786.1996. View

3.
Hebert D, Foellmer B, Helenius A . Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes. EMBO J. 1996; 15(12):2961-8. PMC: 450237. View

4.
Santolini E, Migliaccio G, La Monica N . Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol. 1994; 68(6):3631-41. PMC: 236867. DOI: 10.1128/JVI.68.6.3631-3641.1994. View

5.
Parodi A . Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem J. 2000; 348 Pt 1:1-13. PMC: 1221029. View